Today: 20 May 2026
Coles share price drops 7% after half-year profit slips — what ASX:COL investors watch next
27 February 2026
2 mins read

Coles share price drops 7% after half-year profit slips — what ASX:COL investors watch next

Sydney, February 27, 2026, 16:57 AEDT — After-hours trade.

Shares of Coles Group Ltd (COL.AX) tumbled 7.3% to end Friday at A$20.56, following the release of its half-year results. The stock moved within a range of A$20.10 to A$21.50.

For a stock that investors usually see as a safe spot, the reaction is jarring. It drags up an old worry for the sector: just how much profit can stick around when customers get choosy and the large chains keep squeezing on price.

Earlier this week, Woolworths—Coles’ bigger competitor—posted a first-half profit that topped forecasts. Australian food sales climbed 5.8% in the first seven weeks of the second half, and the stock jumped more than 11%. “The market will get a much clearer picture of how the grocery wars are actually playing out,” said Josh Gilbert, market analyst at eToro, ahead of Coles’ numbers. Reuters

Coles reported a 2.5% lift in group sales revenue, reaching A$23.618 billion for the 27 weeks ended Jan. 4. EBIT, stripping out “significant items,” jumped 10.2% to A$1.231 billion. Net profit after tax (NPAT), though, slid 11.3% to A$511 million following A$235 million in significant items related to a Federal Court judgment from Fair Work Ombudsman proceedings. Excluding those charges, underlying NPAT climbed 12.5% to A$676 million. The board set an interim dividend at 41 Australian cents per share.

Kyle Rodda, senior financial market analyst at Capital.com, pointed to the sell-off as a sign that investors were looking past the headline figures and zeroing in on what the result meant for future trading sessions. The company’s warning about tougher competition, Rodda said, hinted Coles “might be down on the proverbial scorecard right now”. ABC News

Coles Group’s interim dividend—fully franked, so it includes Australian tax credits—lands on March 30. Shares go ex-dividend March 10, cutting off eligibility for the payout. Investors have until March 12, 5 p.m. AEDT, to submit currency choices and make elections for the dividend reinvestment plan.

Coles reported a 3.7% lift in supermarket sales revenue for the first seven weeks of the third quarter—5.3% higher if you strip out tobacco. Liquor sales, still down, eased their slide to a 2.5% decline. The retailer highlighted roughly A$7 million in second-half one-off costs tied to wrapping up its liquor simplification effort, while online sales penetration reached 13.1% for the half. CEO Leah Weckert noted that value “remains front of mind” for shoppers. Other updates: a broader partnership with Uber Eats, and a ChatGPT Enterprise rollout is underway at store support centres. Coles Group

The risk here is straightforward: sharp discounting keeps pressure on margins, and any legal trouble lands at a bad moment. Coles faces a lawsuit from the ACCC, accused of misleading promotions, with closing arguments finishing up this week, according to ABC.

The market’s closed until the next session, so traders are eyeing any signs of further selling or, possibly, some bargain hunting as the dividend date passes and eyes turn to early Q3 sales. Coles’ third-quarter sales update, per its investor calendar, is slated for May 1.

Stock Market Today

  • M&S Leads FTSE Gains on US-Iran Peace Talks and UK Inflation Data
    May 20, 2026, 1:12 PM EDT. The FTSE 100 rose 1.0% to 10,432.34, led by Marks & Spencer after its annual results. Gains came amid US President Donald Trump's comments on nearing a peace deal with Iran, easing geopolitical tensions and causing Brent crude oil prices to fall from $110.72 to $105.26 per barrel. The FTSE 250 also gained 1.2%. UK inflation data showed consumer prices rising 2.8% in April, below expectations, tempering pressure on the Bank of England. Core inflation slowed to 2.5%, with service price inflation easing to 3.2%. Analysts caution this may be a temporary lull due to erratic holiday prices and anticipate forthcoming energy price-driven inflation. Sterling strengthened against the dollar and euro as investors reacted to the positive data and easing geopolitical risks.

Latest articles

Exxon, Chevron Say Oil Reserves Hit by Hormuz Choke, More Volatility Ahead

Six Million Barrels Move Through Hormuz; Major Oil Risk Remains

20 May 2026
Three supertankers carrying 6 million barrels of Middle East crude exited the Strait of Hormuz on Wednesday after waiting over two months, shipping data showed. A fourth tanker was entering the waterway. Brent crude fell over 4% to $106.52 a barrel after President Trump said Iran talks were in “final stages.” The U.S. Navy warned the area remains “high risk” following recent ship attacks.
AAL Shares Rise as Oil Prices Fall

AAL Shares Rise as Oil Prices Fall

20 May 2026
American Airlines shares rose 6.9% to $12.89 midday Wednesday as airline stocks rallied with Brent crude down over 4% after President Trump said U.S.-Iran talks were in “final stages.” CEO Robert Isom will speak at Bernstein’s Strategic Decisions Conference on May 27. American expects to recover up to 85% of higher fuel costs by Q3. The company cut its 2026 outlook in April amid rising jet fuel prices.
Redwire draws attention after latest Army and NATO drone contracts

Redwire draws attention after latest Army and NATO drone contracts

20 May 2026
Redwire shares rose 0.6% to $13.99 after announcing a $15 million U.S. Army drone order and a multi-year NATO contract. The company’s first-quarter net loss widened to $76.5 million, despite revenue jumping 57.9% to $97 million. Redwire may sell up to $350 million in stock through an at-the-market program, according to a May 6 SEC filing.
Vertiv (VRT) stock price dips from record as AI valuation worries bite again
Previous Story

Vertiv (VRT) stock price dips from record as AI valuation worries bite again

GSK share price today: stock edges up after Japan and China reviews, plus $950 million 35Pharma deal
Next Story

GSK share price today: stock edges up after Japan and China reviews, plus $950 million 35Pharma deal

Go toTop